Proteasome inhibitor bortezomib bound to an assembled yeast proteasome core (PDB ID 2F16).

Is Bortezomib a Rare Cause of Acute Pancreatitis?

Tevfik Solakoglu, Mustafa Akar, Tugba Aktan Kosker, Semnur Buyukasik, Osman Ersoy

Abstract


No abstract available.

Image: Proteasome inhibitor bortezomib bound to an assembled yeast proteasome core (PDB ID 2F16). (From Wikimedia Commons).


Keywords


bortezomib; Multiple Myeloma; Pancreatitis, Acute Necrotizing

Full Text:

HTML PDF

References


Elouni B, Ben Salem C, Zamy M, Sakhri J, Bouraoui K, Biour M. Bortezomib-induced acute pancreatitis (Letter). JOP. J pancreas (Online) 2010; 11:275-6.

Kane RC, Bross PF, Farrell AT, Pazdur R. Velcade: U.S. FDA approval for the treatment of multiple myeloma progressing on prior therapy. Oncologist. 2003;8:508-13.

Nitsche CJ, Jamieson N, Lerch MM, Mayerle JV. Drug induced pancreatitis. Best Pract Res Clin Gastroenterol. 2010;24:143-55.

Mihaila RG. A possible rare complication of bortezomib treatment: acute pancreatitis. Acta Medica Transilvanica 2013; 2:269-71.




DOI: http://dx.doi.org/10.6092/1590-8577/1927

NBN: http://nbn.depositolegale.it/urn%3Anbn%3Ait%3Aunina-16062

Article Metrics

Metrics Loading ...

Metrics powered by PLOS ALM

Refbacks

  • There are currently no refbacks.




Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

ISSN 1590-8577 | JOP is published by CAB - Center for Libraries at "Federico II" University of Naples using Open Journal System